卫光生物
(002880)
| 流通市值：60.37亿 | | | 总市值：60.58亿 |
| 流通股本：2.26亿 | | | 总股本：2.27亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 854,101,695.51 | 522,902,745.97 | 226,302,459.95 | 1,048,502,589.77 |
| 营业收入 | 854,101,695.51 | 522,902,745.97 | 226,302,459.95 | 1,048,502,589.77 |
| 二、营业总成本 | 639,313,587.41 | 392,463,709.82 | 171,996,950.01 | 826,102,717.53 |
| 营业成本 | 497,506,182.69 | 304,291,620.64 | 128,362,165.11 | 615,258,881.42 |
| 税金及附加 | 6,785,627.73 | 4,253,939.19 | 1,782,190.54 | 7,794,390.92 |
| 销售费用 | 19,886,380.85 | 12,668,145.68 | 5,219,381.12 | 40,884,889.51 |
| 管理费用 | 62,824,755.16 | 41,303,566.55 | 19,969,094.09 | 86,056,192.35 |
| 研发费用 | 38,106,155.61 | 20,867,745.9 | 12,223,999.54 | 63,616,220.29 |
| 财务费用 | 14,204,485.37 | 9,078,691.86 | 4,440,119.61 | 12,492,143.04 |
| 其中:利息费用 | 15,482,676.74 | 9,985,981.76 | 4,583,750.59 | 15,180,683.8 |
| 其中:利息收入 | 2,001,739.83 | 1,415,108.03 | 368,471.81 | 2,822,371.44 |
| 加:公允价值变动收益 | - | - | - | 2,226,973.85 |
| 加:投资收益 | -120,874.33 | -120,874.33 | - | 5,205,734.81 |
| 资产处置收益 | 45,819.96 | 45,819.96 | - | - |
| 信用减值损失(新) | -3,337,320.33 | -1,595,790.52 | -503,396.46 | 3,226,404.69 |
| 其他收益 | 5,900,526.52 | 3,028,462.57 | 1,577,431.05 | 14,249,689.01 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 217,276,259.92 | 131,796,653.83 | 55,379,544.53 | 247,308,674.6 |
| 加:营业外收入 | 156,818.7 | 150,940.51 | 148,424.41 | 331,094.68 |
| 减:营业外支出 | 779,388.93 | 611,858.86 | 187,315.24 | 2,185,156.75 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 216,653,689.69 | 131,335,735.48 | 55,340,653.7 | 245,454,612.53 |
| 减:所得税费用 | 34,127,310.27 | 21,608,387.65 | 8,546,869.66 | 27,909,976.69 |
| 六、净利润 | 182,526,379.42 | 109,727,347.83 | 46,793,784.04 | 217,544,635.84 |
| 持续经营净利润 | 182,526,379.42 | 109,727,347.83 | 46,793,784.04 | 217,544,635.84 |
| 归属于母公司股东的净利润 | 182,700,428.15 | 109,861,719.65 | 46,831,857.32 | 218,651,341.25 |
| 少数股东损益 | -174,048.73 | -134,371.82 | -38,073.28 | -1,106,705.41 |
| (一)基本每股收益 | 0.81 | 0.48 | 0.21 | 0.96 |
| (二)稀释每股收益 | 0.81 | 0.48 | 0.21 | 0.96 |
| 九、综合收益总额 | 182,526,379.42 | 109,727,347.83 | 46,793,784.04 | 217,544,635.84 |
| 归属于母公司股东的综合收益总额 | 182,700,428.15 | 109,861,719.65 | 46,831,857.32 | 218,651,341.25 |
| 归属于少数股东的综合收益总额 | -174,048.73 | -134,371.82 | -38,073.28 | -1,106,705.41 |
| 公告日期 | 2024-10-26 | 2024-08-28 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |